慢性免疫性血小板减少性紫癜患者的冠状动脉支架置入术：一个临床难题。
Coronary artery stenting in a patient with chronic immune thrombocytopenic purpura: a clinical conundrum.
作者信息
Chan Wah Hak Charleen Min Li, Tan Yew Oo, Chan Charles
机构信息
School of Clinical Medicine, University of Cambridge, Cambridge, UK.
出版信息
BMJ Case Rep. 2012 Sep 24;2012:bcr0220125802. doi: 10.1136/bcr-02-2012-5802.
Abstract
A patient with long-standing immune thrombocytopenic purpura (ITP) would logically contradict antiplatelet use due to increased bleeding risk during coronary stenting. Coronary stenting using an endothelial progenitor cells (EPC) capture stents (Genous™) was used to successfully revascularise our patient using a transradial approach. The only complication was extensive superficial ecchymosis on the patient's forearm from antiplatelet use, which resolved spontaneously. To the best of our knowledge, this is the first case report of EPC capture stents in a chronic ITP patient.
摘要
一名患有长期免疫性血小板减少性紫癜（ITP）的患者，由于冠状动脉支架置入期间出血风险增加，在逻辑上与使用抗血小板药物相矛盾。我们使用内皮祖细胞（EPC）捕获支架（Genous™）通过桡动脉途径成功地为该患者进行了冠状动脉支架置入术，实现血管再通。唯一的并发症是患者前臂因使用抗血小板药物出现广泛的皮下瘀斑，该瘀斑自行消退。据我们所知，这是首例关于慢性ITP患者使用EPC捕获支架的病例报告。
相似文献
1
Coronary artery stenting in a patient with chronic immune thrombocytopenic purpura: a clinical conundrum.慢性免疫性血小板减少性紫癜患者的冠状动脉支架置入术：一个临床难题。
BMJ Case Rep. 2012 Sep 24;2012:bcr0220125802. doi: 10.1136/bcr-02-2012-5802.
2
Coronary revascularization in a patient with immune thrombocytopenic purpura.免疫性血小板减少性紫癜患者的冠状动脉血运重建术。
J Chin Med Assoc. 2006 Sep;69(9):436-8. doi: 10.1016/S1726-4901(09)70287-4.
3
Idiopathic thrombocytopenic purpura and coronary artery disease: comparison between coronary artery bypass grafting and percutaneous coronary intervention.特发性血小板减少性紫癜与冠状动脉疾病：冠状动脉旁路移植术与经皮冠状动脉介入治疗的比较
Interact Cardiovasc Thorac Surg. 2011 Aug;13(2):153-7. doi: 10.1510/icvts.2011.271296. Epub 2011 May 16.
4
Idiopathic thrombocytopenic purpura and percutaneous coronary stenting: a dangerous duo?特发性血小板减少性紫癜与经皮冠状动脉支架置入术：危险组合？
Int J Cardiol. 2008 Nov 28;130(3):e96-7. doi: 10.1016/j.ijcard.2007.06.141. Epub 2007 Sep 12.
5
[Antiplatelet treatment after percutaneous coronary intervention in a patient with idiopathic thrombocytopenic purpura].[特发性血小板减少性紫癜患者经皮冠状动脉介入治疗后的抗血小板治疗]
Turk Kardiyol Dern Ars. 2009 Dec;37(8):575-7.
6
Recurrent acute coronary syndrome and restenosis after percutaneous coronary intervention in a patient with idiopathic thrombocytopenic purpura: a case report and literature review.一名特发性血小板减少性紫癜患者经皮冠状动脉介入治疗后复发性急性冠状动脉综合征和再狭窄：病例报告及文献综述
BMC Cardiovasc Disord. 2015 Sep 18;15:101. doi: 10.1186/s12872-015-0092-3.
7
A Therapeutic Dilemma - Coronary Artery Stenting in the Setting of Thrombocytopaenia.一个治疗难题——血小板减少情况下的冠状动脉支架置入术
Heart Lung Circ. 2015 Dec;24(12):e214-6. doi: 10.1016/j.hlc.2015.08.002. Epub 2015 Aug 20.
8
Immune thrombocytopenic purpura and myocardial infarction: a dilemma of management.免疫性血小板减少性紫癜与心肌梗死：治疗困境
Isr Med Assoc J. 2013 Dec;15(12):775-6.
9
[A case of intracoronary stent implanted for acute myocardial infarction in an elderly patient with idiopathic thrombocytopenic purpura].1例特发性血小板减少性紫癜老年患者急性心肌梗死行冠状动脉内支架植入术
Nihon Ronen Igakkai Zasshi. 2002 Jan;39(1):88-93. doi: 10.3143/geriatrics.39.88.
10
Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura.免疫性血小板减少性紫癜患者的经皮冠状动脉介入治疗
Catheter Cardiovasc Interv. 2004 Mar;61(3):364-7. doi: 10.1002/ccd.10799.
引用本文的文献
1
Concurrent coronary artery disease and immune thrombocytopenia: a systematic review.冠状动脉疾病与免疫性血小板减少症并存：一项系统综述
Front Med (Lausanne). 2023 Oct 10;10:1213275. doi: 10.3389/fmed.2023.1213275. eCollection 2023.
本文引用的文献
1
The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries.Genous™ 内皮祖细胞捕获支架可加速支架再内皮化，但不影响猪冠状动脉内膜增生。
Catheter Cardiovasc Interv. 2012 Feb 1;79(2):231-42. doi: 10.1002/ccd.22928. Epub 2011 Aug 10.
2
Capture of circulatory endothelial progenitor cells and accelerated re-endothelialization of a bio-engineered stent in human ex vivo shunt and rabbit denudation model.在人体旁路和兔去内皮化模型中捕获循环内皮祖细胞并加速生物工程支架的再内皮化。
Eur Heart J. 2012 Jan;33(1):120-8. doi: 10.1093/eurheartj/ehr196. Epub 2011 Jul 6.
3
Incidence, predictors, treatment, and long-term prognosis of patients with restenosis after drug-eluting stent implantation for unprotected left main coronary artery disease.无保护左主干病变经药物洗脱支架置入术后再狭窄患者的发生率、预测因素、治疗及长期预后。
J Am Coll Cardiol. 2011 Mar 22;57(12):1349-58. doi: 10.1016/j.jacc.2010.10.041.
4
Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database.英国普通实践研究数据库中成年原发性免疫性血小板减少症患者的血栓栓塞事件。
Haematologica. 2010 Jul;95(7):1167-75. doi: 10.3324/haematol.2009.018390. Epub 2010 Feb 9.
5
Endothelial progenitor cell capture stent implantation in patients with ST-segment elevation acute myocardial infarction: one year follow-up.支架内捕获内皮祖细胞治疗 ST 段抬高型急性心肌梗死患者：1 年随访。
EuroIntervention. 2010 Jan;5(6):698-702. doi: 10.4244/eijv5i6a115.
6
International consensus report on the investigation and management of primary immune thrombocytopenia.国际原发性免疫性血小板减少症诊治共识报告
Blood. 2010 Jan 14;115(2):168-86. doi: 10.1182/blood-2009-06-225565. Epub 2009 Oct 21.
7
Treatment of immune-mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: a retrospective review of 40 patients.静脉注射免疫球蛋白与血小板输注联合治疗免疫性血小板减少性紫癜：40例患者的回顾性研究
Am J Hematol. 2008 Feb;83(2):122-5. doi: 10.1002/ajh.21060.
8
Idiopathic thrombocytopenic purpura and percutaneous coronary stenting: a dangerous duo?特发性血小板减少性紫癜与经皮冠状动脉支架置入术：危险组合？
Int J Cardiol. 2008 Nov 28;130(3):e96-7. doi: 10.1016/j.ijcard.2007.06.141. Epub 2007 Sep 12.
9
Immune thrombocytopenic purpura.免疫性血小板减少性紫癜
N Engl J Med. 2002 Mar 28;346(13):995-1008. doi: 10.1056/NEJMra010501.
10
Consensus Conference on Platelet Transfusion, Royal College of Physicians of Edinburgh, 27-28 November 1997. Synopsis of background papers.1997年11月27日至28日爱丁堡皇家内科医学院血小板输注共识会议。背景文件概要
Br J Haematol. 1998 Jun;101(4):609-17. doi: 10.1046/j.1365-2141.1998.00773.x.
Zotero 插件